• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索病毒模拟与表观遗传学及肿瘤免疫的结合:癌症治疗的新视角。

Exploring viral mimicry combined with epigenetics and tumor immunity: new perspectives in cancer therapy.

作者信息

Wang Ruirui, Dong Xin, Zhang Xiongjian, Liao Jinzhuang, Cui Wei, Li Wei

机构信息

Department of Radiology, The Third Xiangya Hospital of Central South University. Tongzipo Road 138, Changsha, Hunan, People's Republic of China.

Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Int J Biol Sci. 2025 Jan 6;21(3):958-973. doi: 10.7150/ijbs.103877. eCollection 2025.

DOI:10.7150/ijbs.103877
PMID:39897033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11781167/
Abstract

Viral mimicry refers to an active antiviral response triggered by the activation of endogenous retroviruses (ERVs), usually manifested by the formation of double-stranded RNA (dsRNA) and activation of the cellular interferon response, which activates the immune system and produces anti-tumor effects. Epigenetic studies have shown that epigenetic modifications (e.g. DNA methylation, histone modifications, etc.) play a crucial role in tumorigenesis, progression, and treatment resistance. Particularly, alterations in DNA methylation may be closely associated with the suppression of ERVs expression, and treatment by demethylation may restore ERVs activity and thus strengthen the tumor immune response. Therefore, we propose that viral mimicry can induce immune responses in the tumor microenvironment by activating the expression of ERVs, and that epigenetic alterations may play a key regulatory role in this process. In this paper, we review the intersection of viral mimicry, epigenetics and tumor immunotherapy, and explore the possible interactions and synergistic effects among the three, aiming to provide a new theoretical basis and potential strategies for cancer immunotherapy.

摘要

病毒模拟是指内源性逆转录病毒(ERVs)激活引发的一种主动抗病毒反应,通常表现为双链RNA(dsRNA)的形成和细胞干扰素反应的激活,进而激活免疫系统并产生抗肿瘤作用。表观遗传学研究表明,表观遗传修饰(如DNA甲基化、组蛋白修饰等)在肿瘤发生、发展和治疗抗性中起关键作用。特别是,DNA甲基化的改变可能与ERVs表达的抑制密切相关,而去甲基化治疗可能恢复ERVs活性,从而增强肿瘤免疫反应。因此,我们提出病毒模拟可通过激活ERVs的表达在肿瘤微环境中诱导免疫反应,并且表观遗传改变可能在此过程中起关键调节作用。在本文中,我们综述了病毒模拟、表观遗传学与肿瘤免疫治疗的交叉点,并探讨三者之间可能的相互作用和协同效应,旨在为癌症免疫治疗提供新的理论基础和潜在策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf2/11781167/7dbec82cbf5d/ijbsv21p0958g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf2/11781167/7da7bce2d655/ijbsv21p0958g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf2/11781167/1cee0d29dddb/ijbsv21p0958g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf2/11781167/ccdda1eedeaf/ijbsv21p0958g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf2/11781167/7dbec82cbf5d/ijbsv21p0958g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf2/11781167/7da7bce2d655/ijbsv21p0958g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf2/11781167/1cee0d29dddb/ijbsv21p0958g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf2/11781167/ccdda1eedeaf/ijbsv21p0958g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf2/11781167/7dbec82cbf5d/ijbsv21p0958g004.jpg

相似文献

1
Exploring viral mimicry combined with epigenetics and tumor immunity: new perspectives in cancer therapy.探索病毒模拟与表观遗传学及肿瘤免疫的结合:癌症治疗的新视角。
Int J Biol Sci. 2025 Jan 6;21(3):958-973. doi: 10.7150/ijbs.103877. eCollection 2025.
2
Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation of Interferon Pathway in the Tumor Microenvironment.癌症中的抗病毒反应:通过激活肿瘤微环境中的干扰素通路增强抗肿瘤免疫。
Front Immunol. 2021 Dec 2;12:782852. doi: 10.3389/fimmu.2021.782852. eCollection 2021.
3
The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry.免疫调节抗癌药物RRx-001通过病毒模拟的表观遗传诱导来引发干扰素反应。
Clin Epigenetics. 2017 Jan 19;9:4. doi: 10.1186/s13148-017-0312-z. eCollection 2017.
4
The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.低甲基化剂对基因(重新)表达的双刃剑:从病毒模拟到作为靶向免疫检查点调节的启动剂加以利用
Cell Commun Signal. 2017 Mar 31;15(1):13. doi: 10.1186/s12964-017-0168-z.
5
Endogenous retroviruses in the origins and treatment of cancer.内源性逆转录病毒在癌症的起源和治疗中的作用。
Genome Biol. 2021 May 10;22(1):147. doi: 10.1186/s13059-021-02357-4.
6
Transcription of Endogenous Retroviruses: Broad and Precise Mechanisms of Control.内源性逆转录病毒的转录:广泛而精确的控制机制。
Viruses. 2024 Aug 17;16(8):1312. doi: 10.3390/v16081312.
7
The histone methyltransferase SETDB1 represses endogenous and exogenous retroviruses in B lymphocytes.组蛋白甲基转移酶SETDB1在B淋巴细胞中抑制内源性和外源性逆转录病毒。
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8367-72. doi: 10.1073/pnas.1422187112. Epub 2015 Jun 22.
8
TERT activates endogenous retroviruses to promote an immunosuppressive tumour microenvironment.TERT 通过激活内源性逆转录病毒促进免疫抑制性肿瘤微环境。
EMBO Rep. 2022 Apr 5;23(4):e52984. doi: 10.15252/embr.202152984. Epub 2022 Feb 2.
9
The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy.癌症表观基因组学:利用其脆弱性进行免疫治疗。
Trends Cell Biol. 2019 Jan;29(1):31-43. doi: 10.1016/j.tcb.2018.07.006. Epub 2018 Aug 25.
10
Endogenous Retrovirus Activation as a Key Mechanism of Anti-Tumor Immune Response in Radiotherapy.内源性逆转录病毒激活作为放射治疗抗肿瘤免疫反应的关键机制。
Radiat Res. 2020 Apr;193(4):305-317. doi: 10.1667/RADE-20-00013. Epub 2020 Feb 19.

引用本文的文献

1
Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy.组蛋白去乙酰化酶抑制剂与个性化新抗原疗法(INT)的协同整合:癌症免疫疗法的下一代联合方法
Vaccines (Basel). 2025 May 22;13(6):550. doi: 10.3390/vaccines13060550.
2
Beyond Transposons: as a Pan-Cancer Biomarker and Immune Modulator.超越转座子:作为一种泛癌生物标志物和免疫调节剂。
Genes (Basel). 2025 May 30;16(6):674. doi: 10.3390/genes16060674.

本文引用的文献

1
Epigenetics-targeted drugs: current paradigms and future challenges.表观遗传学靶向药物:当前范例与未来挑战。
Signal Transduct Target Ther. 2024 Nov 26;9(1):332. doi: 10.1038/s41392-024-02039-0.
2
Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathways.通过 RNA 和 DNA 感应途径触发病毒模拟,抑制 EZH2 靶点治疗非典型畸胎样横纹肌样瘤。
Nat Commun. 2024 Oct 29;15(1):9321. doi: 10.1038/s41467-024-53515-8.
3
Epigenetic regulation of tumor immunity.肿瘤免疫的表观遗传调控。
J Clin Invest. 2024 Jun 17;134(12):e178540. doi: 10.1172/JCI178540.
4
Pharmacological targeting of the cancer epigenome.癌症表观基因组的药物靶向治疗。
Nat Cancer. 2024 Jun;5(6):844-865. doi: 10.1038/s43018-024-00777-2. Epub 2024 Jun 27.
5
Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy.双重 DNMT 和 HDAC 抑制剂重塑结直肠癌的免疫微环境,并增强抗 PD-L1 治疗的疗效。
Pharmacol Res. 2024 Aug;206:107271. doi: 10.1016/j.phrs.2024.107271. Epub 2024 Jun 19.
6
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication.癌症免疫治疗中免疫细胞的新见解:从表观遗传修饰、代谢调节到细胞通讯
MedComm (2020). 2024 May 23;5(6):e551. doi: 10.1002/mco2.551. eCollection 2024 Jun.
7
Macrophage based drug delivery: Key challenges and strategies.基于巨噬细胞的药物递送:关键挑战与策略
Bioact Mater. 2024 Apr 23;38:55-72. doi: 10.1016/j.bioactmat.2024.04.004. eCollection 2024 Aug.
8
CDK9 inhibition activates innate immune response through viral mimicry.CDK9 抑制通过模拟病毒激活先天免疫反应。
FASEB J. 2024 Apr 30;38(8):e23628. doi: 10.1096/fj.202302375R.
9
Bifunctional HDAC and DNMT inhibitor induces viral mimicry activates the innate immune response in triple-negative breast cancer.双功能 HDAC 和 DNMT 抑制剂诱导病毒模拟物激活三阴性乳腺癌中的先天免疫反应。
Eur J Pharm Sci. 2024 Jun 1;197:106767. doi: 10.1016/j.ejps.2024.106767. Epub 2024 Apr 16.
10
Ketogenic Diet Alters the Epigenetic and Immune Landscape of Prostate Cancer to Overcome Resistance to Immune Checkpoint Blockade Therapy.生酮饮食改变前列腺癌的表观遗传和免疫景观,以克服对免疫检查点阻断治疗的耐药性。
Cancer Res. 2024 May 15;84(10):1597-1612. doi: 10.1158/0008-5472.CAN-23-2742.